Minimal Residual Disease Monitoring By Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM) in Patients with Multiple Myeloma Receiving Ciltacabtagene Autoleucel

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Oren Pasvolsky, RUCHI SINGHAL, Mahmoud Gaballa, Nilesh M. Kalariya, Jared M. Henderson, Abir Khaled, Zac McDonald, Christen M. Dillard, Liqiang Yang, Robert Z. Orlowski, Krina K. Patel
DOI: 10.1016/j.jtct.2025.12.593
Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments CAR-T cell therapy research Multiple Sclerosis Research Studies

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S412–S413
Publication date
1 February 2026
Language
EN